{
    "sec_cik": "0001578845",
    "sec_company_name": "Actavis plc (Filer)",
    "document_type": "EX991",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20150204",
    "sec_filing_date": "20150210",
    "sec_changed_date": "20150210",
    "sec_accepted_date": "20150210163734",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/1578845/000119312515041667/0001193125-15-041667-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/1578845/000119312515041667/0001193125-15-041667.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0004\004\AGN_0001578845_EX991_20150204_EX-99_metadata.json",
    "original_file_name": "",
    "original_file_size": "14352 chars",
    "document_group": "EX-99",
    "section_name": "EX-99",
    "section_n_characters": 8147,
    "endpoints": [
        "EX-99.1   ",
        "AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com"
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "AGN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0004\004\AGN_0001578845_EX991_20150204_EX-99_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 4,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 21:15:41.037609",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 21:27:19.630862"
}